Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

BACKGROUND: Diabetes is a major cardiovascular risk factor. However, its influence on the rate of occurrence of cardiovascular (CV) events during a clinical trial that included a diabetes subgroup has not yet been quantified. AIMS: To establish equations relating baseline diabetes prevalence and inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermans, Michel P., Bouenizabila, Evariste, Amoussou-guenou, Daniel K., Ahn, Sylvie A., Rousseau, Michel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489105/
https://www.ncbi.nlm.nih.gov/pubmed/25990410
http://dx.doi.org/10.1186/s12933-015-0226-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489105/
https://www.ncbi.nlm.nih.gov/pubmed/25990410
http://dx.doi.org/10.1186/s12933-015-0226-z

Ejemplares similares